Protective Immunity and Defects in the Neonatal and Elderly Immune Response to Sepsis

Populations encompassing extremes of age, including neonates and elderly, have greater mortality from sepsis. We propose that the increased mortality observed in the neonatal and elderly populations after sepsis is due to fundamental differences in host-protective immunity and is manifested at the level of the leukocyte transcriptome. Neonatal (5–7 d), young adult (6–12 wk), or elderly (20–24 mo) mice underwent a cecal slurry model of intra-abdominal sepsis. Both neonatal and elderly mice exhibited significantly greater mortality to sepsis (p < 0.05). Neonates in particular exhibited significant attenuation of their inflammatory response (p < 0.05), as well as reductions in cell recruitment and reactive oxygen species production (both p < 0.05), all of which could be confirmed at the level of the leukocyte transcriptome. In contrast, elderly mice were also more susceptible to abdominal peritonitis, but this was associated with no significant differences in the magnitude of the inflammatory response, reduced bacterial killing (p < 0.05), reduced early myeloid cell activation (p < 0.05), and a persistent inflammatory response that failed to resolve. Interestingly, elderly mice expressed a persistent inflammatory and immunosuppressive response at the level of the leukocyte transcriptome, with failure to return to baseline by 3 d. This study reveals that neonatal and elderly mice have profoundly different responses to sepsis that are manifested at the level of their circulating leukocyte transcriptome, although the net result of increased mortality is similar. Considering these differences are fundamental aspects of the genomic response to sepsis, interventional therapies will require individualization based on the age of the population.

[1]  L. Moldawer,et al.  Role of Innate Immunity in Neonatal Infection , 2013, American Journal of Perinatology.

[2]  C. Orihuela,et al.  Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia , 2012, Experimental Gerontology.

[3]  John D. Storey,et al.  A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.

[4]  S. Olthof,et al.  Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells , 2011, The Journal of experimental medicine.

[5]  C. Coopersmith,et al.  The Role of Heat Shock Protein 70 in Mediating Age-Dependent Mortality in Sepsis , 2011, The Journal of Immunology.

[6]  O. Ramilo,et al.  Challenges in infant immunity: implications for responses to infection and vaccines , 2011, Nature Immunology.

[7]  Jyotika Sharma,et al.  Attenuated Response of Aged Mice to Respiratory Francisella novicida Is Characterized by Reduced Cell Death and Absence of Subsequent Hypercytokinemia , 2010, PloS one.

[8]  H. Wong,et al.  Pathophysiology and treatment of septic shock in neonates. , 2010, Clinics in perinatology.

[9]  C. Orihuela,et al.  Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. , 2009, The Journal of infectious diseases.

[10]  A. Weyrich,et al.  Comment on Chapter 5 , 1999 .

[11]  C. Coopersmith,et al.  Effects of aging on the immunopathologic response to sepsis , 2009, Critical care medicine.

[12]  L. Moldawer,et al.  Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. , 2008, Blood.

[13]  S. Opal,et al.  Sepsis: Time to reconsider the concept , 2008, Critical care medicine.

[14]  L. Moldawer,et al.  INCREASED MORTALITY AND ALTERED IMMUNITY IN NEONATAL SEPSIS PRODUCED BY GENERALIZED PERITONITIS , 2007, Shock.

[15]  N. Weng Aging of the immune system: how much can the adaptive immune system adapt? , 2006, Immunity.

[16]  G. Pawelec,et al.  Aging and innate immunity. , 2006, Immunity.

[17]  Marc Moss,et al.  The effect of age on the development and outcome of adult sepsis* , 2006, Critical care medicine.

[18]  S. Cousens,et al.  4 million neonatal deaths: When? Where? Why? , 2005, The Lancet.

[19]  A. Schuchat,et al.  Trends in Sepsis-Related Neonatal Mortality in the United States, 1985–1998 , 2004, The Pediatric infectious disease journal.

[20]  I. Chaudry,et al.  Are the immune responses different in middle-aged and young mice following bone fracture, tissue trauma and hemorrhage? , 2004, Cytokine.

[21]  C. Coopersmith,et al.  Effects of Age on Mortality and Antibiotic Efficacy in Cecal Ligation and Puncture , 2003, Shock.

[22]  Gilles Clermont,et al.  The epidemiology of severe sepsis in children in the United States. , 2003, American journal of respiratory and critical care medicine.

[23]  L. Moldawer,et al.  SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.

[24]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[25]  D. Bates,et al.  Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997, JAMA.

[26]  Michael T. Bigham,et al.  The Influence of Developmental Age on the Early Transcriptomic Response of Children with Septic Shock , 2011, Molecular medicine.

[27]  I. Chaudry,et al.  Impact of sex and age on bone marrow immune responses in a murine model of trauma-hemorrhage. , 2007, Journal of applied physiology.